granted
on 24 Jan 2024
Last Applicant/ Owned by
Trademark Operations-MS-28-5A
Thousand Oaks
CA
91320-179
Serial Number
97291156 filed on 02th Mar 2022
Registration Number
N/A
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceuticaRead More
pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
No 97291156
No Service/Collective Mark
No TM-2171-US-1
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
26th Jan 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
24th Jan 2024 | SOU TEAS EXTENSION RECEIVED |
24th Jan 2024 | SOU EXTENSION 2 FILED |
24th Jan 2024 | SOU EXTENSION 2 GRANTED |
08th Sep 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
06th Sep 2023 | SOU TEAS EXTENSION RECEIVED |
06th Sep 2023 | SOU EXTENSION 1 FILED |
06th Sep 2023 | SOU EXTENSION 1 GRANTED |
21st Mar 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
24th Jan 2023 | PUBLISHED FOR OPPOSITION |